Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial

Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial

Jonathan Corren,1 Sarbjit S Saini,2 Remi Gagnon,3 Mark H Moss,4 Gordon Sussman,5 Joshua Jacobs,6 Elizabeth Laws,7 Elinore S Chung,8 Tatiana Constant,8 Yiping Sun,8 Jennifer Maloney,8 Jennifer D Hamilton,8 Marcella Ruddy,8 Claire Q Wang,8 Meagan P O’Brien8 1Departments of Medicine and Pediatrics, Dav...

Full description

Bibliographic Details
Main Authors: Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O’Brien MP
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Journal of Asthma and Allergy
Subjects:
dupilumab
seasonal allergic rhinitis
subcutaneous immunotherapy
nasal allergen responses
Online Access:https://www.dovepress.com/short-term-subcutaneous-allergy-immunotherapy-and-dupilumab-are-well-t-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/short-term-subcutaneous-allergy-immunotherapy-and-dupilumab-are-well-t-peer-reviewed-fulltext-article-JAA

Similar Items